Key metrics to watch: Organic sales growth excluding FX and divestitures, with focus on volume versus price/mix contribution · Adjusted EBITDA margin and progression toward mid-teens target as standalone company scales · Free cash flow conversion rate and working capital efficiency post-separation from J&J systems · Nielsen/IRI market share data for Tylenol (analgesics), Listerine (mouthwash), and Neutrogena (facial skincare) categories